Mark Hensley
Corporate Officer/Principal bij VELOXIS PHARMACEUTICALS A/S
Actieve functies van Mark Hensley
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| VELOXIS PHARMACEUTICALS A/S | Corporate Officer/Principal | 03-01-2019 | - |
| Verkoop & Marketing | 01-04-2016 | 03-01-2019 |
Loopbaan van Mark Hensley
Opleiding van Mark Hensley
| University of North Texas | Undergraduate Degree |
Statistieken
Internationaal
| Denemarken | 2 |
| Verenigde Staten | 2 |
Operationeel
| Corporate Officer/Principal | 1 |
| Sales & Marketing | 1 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 2 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Veloxis Pharmaceuticals A/S
 Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Veloxis Pharmaceuticals A/S is a commercial-stage specialty pharmaceutical company, which engages in the development and commercialization of medicine for the prevention of organ rejection in kidney transplant patients. The company is focused on the direct commercialization of Envarsus XR in the US, expansion of partnerships for markets, and acquisition of assets utilized in transplant patients and by adjacent medical specialties. Veloxis Pharmaceuticals was founded in June 2002 and is headquartered in Copenhagen, Denmark. | Health Technology |
- Beurs
- Insiders
- Mark Hensley
- Ervaring
